Fresenius Medical Care AG & Co. KGaA (FMCQF)
USD 46.12
(-2.91%)
USD 46.12
(-2.91%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.55 Billion EUR | -9.39% |
| 2022 | 3.8 Billion EUR | 8.77% |
| 2021 | 3.49 Billion EUR | -14.25% |
| 2020 | 4.08 Billion EUR | 11.75% |
| 2019 | 3.65 Billion EUR | 29.48% |
| 2018 | 2.81 Billion EUR | -19.11% |
| 2017 | 3.48 Billion EUR | 6.5% |
| 2016 | 3.27 Billion EUR | 13.28% |
| 2015 | 2.88 Billion EUR | 26.99% |
| 2014 | 2.27 Billion EUR | 24.79% |
| 2013 | 1.82 Billion EUR | -1.03% |
| 2012 | 1.84 Billion EUR | -3.6% |
| 2011 | 1.91 Billion EUR | 14.43% |
| 2010 | 1.66 Billion EUR | 15.25% |
| 2009 | 1.44 Billion EUR | 3.1% |
| 2008 | 1.4 Billion EUR | 15.39% |
| 2007 | 1.21 Billion EUR | 3.07% |
| 2006 | 1.18 Billion EUR | 0.41% |
| 2005 | 1.17 Billion EUR | 29.32% |
| 2004 | 909.95 Million EUR | 6.96% |
| 2003 | 850.77 Million EUR | -7.11% |
| 2002 | 915.85 Million EUR | -35.32% |
| 2001 | 1.41 Billion EUR | 57.21% |
| 2000 | 900.69 Million EUR | -20.49% |
| 1999 | 1.13 Billion EUR | 21.86% |
| 1998 | 929.56 Million EUR | 0.0% |
| 1997 | - EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 813.79 Million EUR | 16.47% |
| 2024 Q1 | 957 Million EUR | -23.3% |
| 2023 Q3 | 830.27 Million USD | -5.36% |
| 2023 Q1 | 879.73 Million USD | -19.18% |
| 2023 Q2 | 877.27 Million USD | -0.28% |
| 2023 Q4 | 979.56 Million EUR | 17.98% |
| 2023 FY | 3.44 Billion EUR | -9.39% |
| 2022 FY | 3.8 Billion EUR | 8.77% |
| 2022 Q4 | 1.08 Billion EUR | 5.66% |
| 2022 Q3 | 1.03 Billion EUR | 0.51% |
| 2022 Q2 | 1.02 Billion EUR | 11.87% |
| 2022 Q1 | 916.12 Million EUR | 12.51% |
| 2021 Q1 | 893.41 Million EUR | -4.12% |
| 2021 Q4 | 814.22 Million EUR | 4.77% |
| 2021 Q3 | 777.16 Million EUR | -11.91% |
| 2021 Q2 | 882.19 Million EUR | -1.26% |
| 2021 FY | 3.49 Billion EUR | -14.25% |
| 2020 Q1 | 900.37 Million EUR | 4.35% |
| 2020 Q3 | 762.67 Million EUR | -3.34% |
| 2020 Q4 | 931.79 Million EUR | 22.17% |
| 2020 FY | 4.08 Billion EUR | 11.75% |
| 2020 Q2 | 789 Million EUR | -12.37% |
| 2019 FY | 3.65 Billion EUR | 29.48% |
| 2019 Q3 | 773.6 Million EUR | -8.29% |
| 2019 Q4 | 862.83 Million EUR | 11.53% |
| 2019 Q2 | 843.54 Million EUR | 12.66% |
| 2019 Q1 | 748.77 Million EUR | -2.42% |
| 2018 Q4 | 767.37 Million EUR | -0.14% |
| 2018 Q1 | 724 Million EUR | -26.84% |
| 2018 Q2 | 752.82 Million EUR | 3.98% |
| 2018 Q3 | 768.42 Million EUR | 2.07% |
| 2018 FY | 2.81 Billion EUR | -19.11% |
| 2017 Q3 | 828.92 Million EUR | -11.31% |
| 2017 FY | 3.48 Billion EUR | 6.5% |
| 2017 Q1 | 955.26 Million EUR | 4.71% |
| 2017 Q2 | 934.64 Million EUR | -2.16% |
| 2017 Q4 | 989.64 Million EUR | 19.39% |
| 2016 FY | 3.27 Billion EUR | 13.28% |
| 2016 Q3 | 740.49 Million EUR | 6.84% |
| 2016 Q1 | 702.29 Million EUR | -12.61% |
| 2016 Q4 | 912.25 Million EUR | 23.2% |
| 2016 Q2 | 693.05 Million EUR | -1.32% |
| 2015 Q1 | 633.33 Million EUR | -8.19% |
| 2015 FY | 2.88 Billion EUR | 26.99% |
| 2015 Q4 | 803.62 Million EUR | 16.33% |
| 2015 Q3 | 690.78 Million EUR | 2.34% |
| 2015 Q2 | 675.01 Million EUR | 6.58% |
| 2014 Q3 | 552.15 Million EUR | 13.91% |
| 2014 FY | 2.27 Billion EUR | 24.79% |
| 2014 Q4 | 689.87 Million EUR | 24.94% |
| 2014 Q2 | 484.75 Million EUR | 2.61% |
| 2014 Q1 | 472.44 Million EUR | 7.28% |
| 2013 Q4 | 440.36 Million EUR | -3.81% |
| 2013 FY | 1.82 Billion EUR | -1.03% |
| 2013 Q3 | 457.8 Million EUR | -4.9% |
| 2013 Q2 | 481.38 Million EUR | -0.9% |
| 2013 Q1 | 485.77 Million EUR | -6.55% |
| 2012 Q2 | 447.51 Million EUR | 2.69% |
| 2012 Q4 | 519.83 Million EUR | 21.35% |
| 2012 Q3 | 428.37 Million EUR | -4.28% |
| 2012 Q1 | 435.8 Million EUR | -21.13% |
| 2012 FY | 1.84 Billion EUR | -3.6% |
| 2011 Q1 | 423.25 Million EUR | -8.5% |
| 2011 Q4 | 552.58 Million EUR | 19.88% |
| 2011 Q2 | 429.13 Million EUR | 1.39% |
| 2011 Q3 | 460.94 Million EUR | 7.41% |
| 2011 FY | 1.91 Billion EUR | 14.43% |
| 2010 FY | 1.66 Billion EUR | 15.25% |
| 2010 Q1 | 402.83 Million EUR | -3.92% |
| 2010 Q4 | 462.55 Million EUR | 12.32% |
| 2010 Q3 | 411.81 Million EUR | -8.25% |
| 2010 Q2 | 448.85 Million EUR | 11.42% |
| 2009 Q2 | 366.41 Million EUR | 4.21% |
| 2009 Q1 | 351.59 Million EUR | -6.96% |
| 2009 FY | 1.44 Billion EUR | 3.1% |
| 2009 Q4 | 419.28 Million EUR | 16.47% |
| 2009 Q3 | 360 Million EUR | -1.75% |
| 2008 Q2 | 314.44 Million EUR | 6.42% |
| 2008 FY | 1.4 Billion EUR | 15.39% |
| 2008 Q1 | 295.46 Million EUR | -2.1% |
| 2008 Q3 | 345.54 Million EUR | 9.89% |
| 2008 Q4 | 377.88 Million EUR | 9.36% |
| 2007 Q4 | 301.81 Million EUR | -2.39% |
| 2007 Q2 | 329.74 Million EUR | 4.97% |
| 2007 FY | 1.21 Billion EUR | 3.07% |
| 2007 Q1 | 314.14 Million EUR | -1.77% |
| 2007 Q3 | 309.2 Million EUR | -6.23% |
| 2006 Q1 | 275.92 Million EUR | -15.37% |
| 2006 Q4 | 319.79 Million EUR | 0.97% |
| 2006 Q3 | 316.72 Million EUR | 13.28% |
| 2006 FY | 1.18 Billion EUR | 0.41% |
| 2006 Q2 | 279.6 Million EUR | 1.33% |
| 2005 FY | 1.17 Billion EUR | 29.32% |
| 2005 Q4 | 326.03 Million EUR | 10.31% |
| 2005 Q1 | 246.07 Million EUR | 31.76% |
| 2005 Q3 | 295.56 Million EUR | 2.56% |
| 2005 Q2 | 288.18 Million EUR | 17.11% |
| 2004 Q2 | 256.17 Million EUR | 11.22% |
| 2004 FY | 909.95 Million EUR | 6.96% |
| 2004 Q4 | 186.76 Million EUR | -23.37% |
| 2004 Q1 | 230.32 Million EUR | 22.96% |
| 2004 Q3 | 243.71 Million EUR | -4.86% |
| 2003 Q1 | 227.08 Million EUR | 6.3% |
| 2003 Q3 | 228.5 Million EUR | 1.55% |
| 2003 FY | 850.77 Million EUR | -7.11% |
| 2003 Q4 | 187.32 Million EUR | -18.02% |
| 2003 Q2 | 225.01 Million EUR | -0.91% |
| 2002 FY | 915.85 Million EUR | -35.32% |
| 2002 Q3 | 256.2 Million EUR | 7.39% |
| 2002 Q2 | 238.58 Million EUR | 2.22% |
| 2002 Q1 | 233.39 Million EUR | -62.0% |
| 2002 Q4 | 213.62 Million EUR | -16.62% |
| 2001 Q4 | 614.16 Million EUR | 120.68% |
| 2001 Q2 | 287.65 Million EUR | 8.4% |
| 2001 FY | 1.41 Billion EUR | 57.21% |
| 2001 Q1 | 265.37 Million EUR | 584.51% |
| 2001 Q3 | 278.31 Million EUR | -3.25% |
| 2000 Q1 | 290.73 Million EUR | 108.92% |
| 2000 Q4 | -54.77 Million EUR | -111.34% |
| 2000 Q3 | 482.83 Million EUR | 119.4% |
| 2000 Q2 | 220.06 Million EUR | -24.31% |
| 2000 FY | 900.69 Million EUR | -20.49% |
| 1999 Q3 | - EUR | 0.0% |
| 1999 FY | 1.13 Billion EUR | 21.86% |
| 1999 Q2 | - EUR | 0.0% |
| 1999 Q1 | - EUR | 100.0% |
| 1999 Q4 | -3.25 Billion EUR | 0.0% |
| 1998 Q4 | -2.57 Billion EUR | 0.0% |
| 1998 Q1 | - EUR | 0.0% |
| 1998 Q3 | - EUR | 0.0% |
| 1998 FY | 929.56 Million EUR | 0.0% |
| 1998 Q2 | - EUR | 0.0% |
| 1997 Q2 | - EUR | 0.0% |
| 1997 FY | - EUR | 0.0% |
| 1997 Q4 | - EUR | 0.0% |
| 1997 Q3 | - EUR | 0.0% |
| 1997 Q1 | - EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| The Amacore Group, Inc. | 64.06 Million USD | -5449.638% |
| Arem Pacific Corporation | 367.08 Thousand USD | -968508.205% |
| Assisted 4 Living, Inc. | 833.9 Thousand USD | -426275.546% |
| BioCorRx Inc. | 3.84 Million USD | -92469.507% |
| Bionik Laboratories Corp. | 5.81 Million USD | -61045.63% |
| Banyan Corp. | 6.59 Million USD | -53792.053% |
| Clearday, Inc. | 5 Million USD | -70972.676% |
| Dental Patient Care America, Inc. | 3.27 Million USD | -108438.43% |
| Quantum Medical Transport, Inc. | 874.76 USD | -406461901.006% |
| Empower Clinics Inc. | 6.92 Million USD | -51263.687% |
| First Choice Healthcare Solutions, Inc. | 2.44 Million USD | -145595.179% |
| Selectis Health, Inc. | 14.36 Million USD | -24647.213% |
| Ethema Health Corporation | 5.27 Million USD | -67341.152% |
| HealthLynked Corp. | 9.73 Million USD | -36436.346% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.43 Million USD | -37568.967% |
| JRSIS Health Care Corporation | 671.64 Thousand USD | -529278.738% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 75.35 Million USD | -4618.229% |
| MedSmart Group Inc. | 65.47 Thousand USD | -5430651.02% |
| North America Frac Sand, Inc. | 775.75 Thousand USD | -458236.33% |
| Nova Leap Health Corp. | 9.3 Million USD | -38098.116% |
| Nexteligent Holdings, Inc. | 553.38 Thousand USD | -642407.712% |
| PAO Group, Inc. | 45.42 Thousand USD | -7828096.83% |
| Primemd Inc. | 6.25 Million USD | -56717.446% |
| Raffles Medical Group Ltd | 151.69 Million USD | -2243.96% |
| Ryman Healthcare Limited | 9.61 Million USD | -36886.923% |
| Stem Cell Authority, Ltd. | 4233.00 USD | -83996285.542% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.38 Million USD | -257405.542% |
| Mycotopia Therapies, Inc. | 616.72 Thousand USD | -576424.831% |
| U.S. NeuroSurgical Holdings, Inc. | 765 Thousand USD | -464680.0% |
| Veltex Corporation | 1.77 Million USD | -199975.685% |
| World Financial Holding Group | 28.42 Thousand USD | -12508050.989% |
| Xcelerate Inc. | 2.9 Million USD | -122219.657% |